Accolade Inc
NASDAQ:ACCD
Accolade Inc
Total Liabilities & Equity
Accolade Inc
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Accolade Inc
NASDAQ:ACCD
|
Total Liabilities & Equity
$903.1m
|
CAGR 3-Years
131%
|
CAGR 5-Years
81%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Total Liabilities & Equity
$17.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
0%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Liabilities & Equity
$14B
|
CAGR 3-Years
0%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
|
CVS Health Corp
NYSE:CVS
|
Total Liabilities & Equity
$249.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
13%
|
|
Cigna Corp
NYSE:CI
|
Total Liabilities & Equity
$153.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
11%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Liabilities & Equity
$16.5B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
9%
|
See Also
What is Accolade Inc's Total Liabilities & Equity?
Total Liabilities & Equity
903.1m
USD
Based on the financial report for Feb 28, 2023, Accolade Inc's Total Liabilities & Equity amounts to 903.1m USD.
What is Accolade Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
81%
Over the last year, the Total Liabilities & Equity growth was -30%. The average annual Total Liabilities & Equity growth rates for Accolade Inc have been 131% over the past three years , 81% over the past five years .